Literature DB >> 19302746

Clinical assessment of awake endotracheal intubation using the lightwand technique alone in patients with difficult airways.

Fu-shan Xue1, Nong He, Xu Liao, Xiu-Zheng Xu, Ya-chao Xu, Quan-yong Yang, Mao-ping Luo, Yan-ming Zhang.   

Abstract

BACKGROUND: There is few study to determine whether the use of the lightwand technique alone could achieve effective, safe and successful awake endotracheal intubation (ETI), therefore we designed a prospective clinical study to systematically evaluate the feasibility, safety and efficacy of awake ETI using the lightwand alone in patients with difficult airways.
METHODS: Seventy adult patients with difficult airways were enrolled in this study. After the desired sedation with fentanyl and midazolam, airway topical anesthesia was performed with 9 ml of 2% lidocaine, which were in order sprayed in three aliquots at 5 minutes intervals into the supraglottic (two doses) and laryngotracheal areas (one dose) using a combined unit of the lightwand and MADgic atomizer. After airway topical anesthesia, awake ETI was performed using a Lightwand. Subjective assessments by patients and operators using the visual analogue scores (VAS), and objective assessments by an independent investigator using patients' tolerance and reaction scores, coughing severity, intubating conditions and cardiovascular variables were taken as the observed parameters.
RESULTS: Of 210 airway sprays, 197 (93.8%) were successfully completed on the first attempt. The total time for airway spray was (14.6 +/- 1.5) minutes. During airway topical anesthesia, the average patients' tolerance scores were 1.7 - 2.3. After airway topical anesthesia, the mean VAS for discomfort levels that the patients reported was 6.5. Also airway topical anesthesia procedure was rated as acceptable and no discomfort by 94.3% of patients. The lightwand-guided awake ETI was successfully completed on first attempt within 29 seconds in all patients. During awake ETI, patients' reaction and coughing scores were 1.9 and 1.6, respectively. All patients exhibited excellent or acceptable intubating conditions. Cardiovascular monitoring revealed that changes of systolic blood pressure and heart rate at each stage of airway manipulations were less than 20% of baseline values. The postoperative follow-up showed that 95.7% of patients had no recall or slight memories of all airway instrumentation. The incidence of postoperative mild airway complications was 38.6%.
CONCLUSION: Alone use of the lightwand technique can achieve effective, safe and successful awake ETI in patients with difficult airways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302746

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Quest for an ideal intubating device.

Authors:  Goneppanavar Umesh
Journal:  Oman Med J       Date:  2012-03

2.  Tramadol combined with fentanyl in awake endotracheal intubation.

Authors:  Sai-Ying Wang; Yang Mei; Hui Sheng; Yang Li; Rui Han; Cheng-Xuan Quan; Zhong-Hua Hu; Wen Ouyang; Zhao-Qian Liu; Kai-Ming Duan
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

3.  Comparison between dexmedetomidine and fentanyl on intubation conditions during awake fiberoptic bronchoscopy: A randomized double-blind prospective study.

Authors:  Sudeshna Mondal; Sarmila Ghosh; Susmita Bhattacharya; Brojen Choudhury; Suchismita Mallick; Anu Prasad
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Apr-Jun

4.  Facilitation of fiberoptic nasotracheal intubation with magnesium sulfate: A double-blind randomized study.

Authors:  Ahmed Said Elgebaly; Ahmed Ali Eldabaa
Journal:  Anesth Essays Res       Date:  2014 Sep-Dec

5.  Evaluation of Effectiveness of Dexmedetomidine and Fentanyl-midazolam Combination on Sedation and Safety during Awake Fiberoptic Intubation: A Randomized Comparative Study.

Authors:  Abida Yousuf; Basharat Ahad; Aabid Hussain Mir; Abdul Waheed Mir; Juvera Gul Wani; Sheikh Quyoom Hussain
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.